<DOC>
	<DOCNO>NCT02813876</DOCNO>
	<brief_summary>Prospective randomized-controlled trial evaluate impact enhance recovery protocol compare standard care recovery patient acute pancreatitis .</brief_summary>
	<brief_title>Enhanced Recovery Acute Pancreatitis</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<criteria>Acute pancreatitis confirm clinical history , serologic test and/or radiographic image â€¢ Severe acute pancreatitis define presence following : Organ failure ( oxygen saturation &lt; 90 % room air , mean arterial pressure &lt; 70 mmHG requirement vasopressor inotropic support , serum creatinine &gt; 2.0 , Glasgow coma score &lt; 15 ) Suspected confirm infected pancreatic necrosis : fever , leukocytosis set suspicious finding crosssectional imaging ( gas within necrotic collection ) confirm infection fine needle aspirate Chronic pancreatitis chronic pain syndrome requiring use narcotic analgesic within 30 day prior hospitalization Abdominal surgery within 60 day prior hospitalization History gastrointestinal motility disorder Inflammatory bowel disease Chronic comorbid illness include limited &gt; New York Heart Association Class II congestive heart failure , cirrhosis , oxygendependent chronic obstructive pulmonary disease malignancy nonsquamous skin cancer remission . Documented allegy follow medication : dilaudid , Tylenol Patients transfer outside hospital ongoing care NonEnglish speaking patient appropriate language interpretor identify . Pregnant woman exclude participation phase IIb trial give limited project sample size rarity condition pregnancy . Minors ( patient &lt; 18 year age ) eligible study inclusion . The intervention compare study protocol standard care adult patient acute pancreatitis . However , safety efficacy treatment pediatric population establish .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>